|
Post by agedhippie on Feb 1, 2019 15:15:58 GMT -5
And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. Try optimism..and take a little risk..other wise you can't advance.. And that answers the question about overcharging how?
|
|
|
Post by boca1girl on Feb 1, 2019 16:11:03 GMT -5
Sanofi set the price of Mannkinds insulin..and it was Mannkind that lowered the price..Sanofi is flatlined..Mannkind has a sea of potential patient growth..and unlike Sanofi and other large pharma doesn't need to raise prices to grow..just need to increase the patient base...which is occuring..Large Pharma has a real problem..that Mannkind is looking to me like the solution.. And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. But aren’t all drugs priced lower outside the US? If the RAAs are at lower prices outside the US, Afrezza will have to be priced less outside the US also. I think we all realize that. I don’t understand your point.
|
|
|
Post by sportsrancho on Feb 1, 2019 18:47:23 GMT -5
And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. But aren’t all drugs priced lower outside the US? If the RAAs are at lower prices outside the US, Afrezza will have to be priced less outside the US also. I think we all realize that. I don’t understand your point. There is already people looking forward to crossing the border🤣 One of my clients gets his anabiotic‘s over there and another one gets their dental work done. Jackie and I got our Retin-A over there for years. Can’t wait for Afrezza in Mexico and Canada!
|
|
|
Post by sellhighdrinklow on Feb 1, 2019 22:09:34 GMT -5
And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. But aren’t all drugs priced lower outside the US? If the RAAs are at lower prices outside the US, Afrezza will have to be priced less outside the US also. I think we all realize that. I don’t understand your point. As I've pointed out previously, Agedhippie just might be here for a reason. ....he/she/they and several others. This thread is spot on. And why I've averaged down through it all but still wish I'd sold a few thousand more shares back I'm October....17? 🙃
|
|
|
Post by agedhippie on Feb 1, 2019 22:55:23 GMT -5
And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. But aren’t all drugs priced lower outside the US? If the RAAs are at lower prices outside the US, Afrezza will have to be priced less outside the US also. I think we all realize that. I don’t understand your point. My point is why can Mannkind not reduce the price in the US to what would be charged outside the US? Is the defense that everyone else is overcharging the US market so we should as well? If that is the case, and there are a lot of good reasons why it should be, then fine but can we drop the moral outrage about insulin prices since we are in the same boat with the others? On the positive side; a price reduction of that magnitude would force Afrezza into the SOC because the cost benefit even with the current non-inferior label would be overwhelming. The PBM resistance would become irrelevant since it would be cheaper to buy direct than on insurance.
|
|
|
Post by peppy on Feb 1, 2019 23:10:42 GMT -5
But aren’t all drugs priced lower outside the US? If the RAAs are at lower prices outside the US, Afrezza will have to be priced less outside the US also. I think we all realize that. I don’t understand your point. My point is why can Mannkind not reduce the price in the US to what would be charged outside the US? Is the defense that everyone else is overcharging the US market so we should as well? If that is the case, and there are a lot of good reasons why it should be, then fine but can we drop the moral outrage about insulin prices since we are in the same boat with the others? On the positive side; a price reduction of that magnitude would force Afrezza into the SOC because the cost benefit even with the current non-inferior label would be overwhelming. The PBM resistance would become irrelevant since it would be cheaper to buy direct than on insurance. oh aged, why can't Sanofi, Lilly, and Novo Nordisk, charge the US what they charge in the EU? eh?
|
|
|
Post by agedhippie on Feb 1, 2019 23:17:38 GMT -5
My point is why can Mannkind not reduce the price in the US to what would be charged outside the US? Is the defense that everyone else is overcharging the US market so we should as well? If that is the case, and there are a lot of good reasons why it should be, then fine but can we drop the moral outrage about insulin prices since we are in the same boat with the others? On the positive side; a price reduction of that magnitude would force Afrezza into the SOC because the cost benefit even with the current non-inferior label would be overwhelming. The PBM resistance would become irrelevant since it would be cheaper to buy direct than on insurance. oh aged, why can't Sanofi, Lilly, and Novo Nordisk, charge the US what they charge in the EU? eh? Because they are a thieving bunch of [fill in your favorite expletive here]. Change the law so Medicare/Medicaid can negotiate and they should be able to get the price they pay down to the EU levels. But that needs Congress to support voters rather than pharmas.
|
|
|
Post by peppy on Feb 1, 2019 23:32:59 GMT -5
oh aged, why can't Sanofi, Lilly, and Novo Nordisk, charge the US what they charge in the EU? eh? Because they are a thieving bunch of [fill in your favorite expletive here]. Change the law so Medicare/Medicaid can negotiate and they should be able to get the price they pay down to the EU levels. But that needs Congress to support voters rather than pharmas. yep. laws and EPS. yep. aged, are you an American citizen? Born in the USA? I am asking because, of your Europe awareness. yikes.
|
|
|
Post by majorwood on Feb 1, 2019 23:53:10 GMT -5
The market is totally irrational which makes for an incredible multi year buying opportunity. Stranger than monkey shi_ but I'll take it.
|
|
|
Post by akemp3000 on Feb 2, 2019 4:32:08 GMT -5
The market is totally irrational which makes for an incredible multi year buying opportunity. Stranger than monkey shi_ but I'll take it. Irrational and corrupt!
|
|
|
Post by Clement on Feb 2, 2019 8:31:54 GMT -5
The market is totally irrational which makes for an incredible multi year buying opportunity. Stranger than monkey shi_ but I'll take it. <iframe width="23.200000000000045" height="2.9200000000000017" style="position: absolute; width: 23.2px; height: 2.92px; z-index: -9999; border-style: none; left: 14px; top: -5px;" id="MoatPxIOPT0_25990449" scrolling="no"></iframe> <iframe width="23.200000000000045" height="2.9200000000000017" style="position: absolute; width: 23.2px; height: 2.92px; z-index: -9999; border-style: none; left: 1101px; top: -5px;" id="MoatPxIOPT0_35601075" scrolling="no"></iframe> <iframe width="23.200000000000045" height="2.9200000000000017" style="position: absolute; width: 23.2px; height: 2.92px; z-index: -9999; border-style: none; left: 14px; top: 87px;" id="MoatPxIOPT0_46831601" scrolling="no"></iframe> <iframe width="23.200000000000045" height="2.9200000000000017" style="position: absolute; width: 23.2px; height: 2.92px; z-index: -9999; border-style: none; left: 1101px; top: 87px;" id="MoatPxIOPT0_29013328" scrolling="no"></iframe> Yes. I bought more MNKD last week.
|
|
|
Post by radgray68 on Feb 2, 2019 10:27:53 GMT -5
FDA regulations and too many lawyers = higher prices (Drop mic)
|
|
|
Post by MnkdWASmyRtrmntPlan on Feb 2, 2019 10:49:41 GMT -5
And my point is that Mannkind is either overcharging like all the rest, or is not going to be able to compete outside the US any time soon because of price. The world price RAA is a long way below $4 per day. Try optimism..and take a little risk..other wise you can't advance.. mlpforums.com/blogs/entry/20252-why-pessimism-is-annoying-opinion/
|
|
|
Post by agedhippie on Feb 2, 2019 11:21:05 GMT -5
The comment section is worth reading as well.
|
|
|
Post by agedhippie on Feb 2, 2019 11:25:49 GMT -5
Because they are a thieving bunch of [fill in your favorite expletive here]. Change the law so Medicare/Medicaid can negotiate and they should be able to get the price they pay down to the EU levels. But that needs Congress to support voters rather than pharmas. yep. laws and EPS. yep. aged, are you an American citizen? Born in the USA? I am asking because, of your Europe awareness. yikes. I have a green card. I have lived here just over 20 years now. I use the UK and Europe as examples because of the relative size to the US, and because the pricing data is relatively easy to get (especially for the UK). Also the UK publishes a lot of data sets from the NHS and they are sometimes useful to look at.
|
|